Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms- |
Target |
Mechanism GPC3 modulators(Glypican-3 modulators), NKp46 inhibitors(Natural cytotoxicity triggering receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | US | Cytovia Therapeutics, Inc.Startup | 17 Apr 2023 |
Hepatocellular Carcinoma | Preclinical | FR | 17 Apr 2023 |